These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 887227)

  • 1. [Monocomponent insulins].
    Rodríguez-Miñón JL
    Minerva Med; 1977 Jul; 68(35):2485-90. PubMed ID: 887227
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.
    Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C
    Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720
    [No Abstract]   [Full Text] [Related]  

  • 6. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of purified bovine and monocomponent porcine insulins.
    Johnson Z; McDonnell J; Devlin JG
    Ir Med J; 1984 Dec; 77(12):380-1, 383. PubMed ID: 6394540
    [No Abstract]   [Full Text] [Related]  

  • 9. Monocomponent insulin in maturity onset diabetes mellitus.
    Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M
    J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monocomponent insulins (author's transl)].
    Rodriguez-Miñón JL
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1215-20. PubMed ID: 409943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monocomponet insulins].
    Rodríguez-Miñón JL
    Rev Clin Esp; 1978 Mar; 148(6):579-82. PubMed ID: 663334
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibodies to insulin in patients with diabetes mellitus].
    Kozopolianskaia MM; Poltorak VV; Stetsenko KP
    Vrach Delo; 1973 Feb; 2():110-2. PubMed ID: 4722307
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of insulin antibodies in insulin treated patients.
    Giampietro O; Giannessi D; Del Chicca MG; Luche AD; Zucchelli GC; Navalesi R
    J Nucl Med Allied Sci; 1980; 24(3-4):153-8. PubMed ID: 7019394
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenic properties of a highly purified insulin preparation.
    Manning NT; Drury MI
    Ir J Med Sci; 1979 Apr; 148(4):135-9. PubMed ID: 393651
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical aspects of monocomponent insulins in the treatment of diabetes.
    Vinik AI; Joffe BI; Seftel HC; Distiller LA; Jackson WP
    S Afr Med J; 1976 Apr; 50(15):587-91. PubMed ID: 1265555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
    Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
    Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin antibodies in diabetes.
    Lev-Ran A; Joshua H; Mannheimer S
    Isr J Med Sci; 1971 Sep; 7(9):1035-9. PubMed ID: 5170197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.